The trial teams in Bern, Gent, Lugano and Durham randomised one new patient each and one new site was opened in Drammen, Norway. We have now recruited a total of 1619 patients in 94 sites. Many thanks to all the teams for their support! Four new patients randomised and one new site opened!March 16, 2022 in News by stabend
